Business Segments · Depreciation

Life Sciences and Emerging Growth Businesses — Depreciation

Corning Life Sciences and Emerging Growth Businesses — Depreciation decreased by 10.3% to $26.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2025
Last reportedQ1 2026

How to read this metric

An increase often correlates with recent capital investments, while a decrease may signal aging infrastructure or reduced asset utilization.

Detailed definition

This metric represents the systematic allocation of the cost of tangible assets used within the Life Sciences and Emergi...

Peer comparison

Comparable to depreciation and amortization charges in capital-intensive manufacturing segments.

Metric ID: glw_segment_life_sciences_and_emerging_growth_businesses_depreciation

Historical Data

2 periods
 Q1 '25Q1 '26
Value$29.00M$26.00M
QoQ Change-10.3%
YoY Change-10.3%
Range$26.00M$29.00M
Avg YoY Growth-10.3%
Median YoY Growth-10.3%

Frequently Asked Questions

What is Corning's life sciences and emerging growth businesses — depreciation?
Corning (GLW) reported life sciences and emerging growth businesses — depreciation of $26.00M in Q1 2026.
What does life sciences and emerging growth businesses — depreciation mean?
The non-cash expense representing the wear and tear of assets in the Life Sciences and Emerging Growth segment.